Latent TB (Part 4) – acquired immunity and mixed infections
Let’s set the scene by starting with some much-needed good news. Protection from further infection afforded by a TB infection In the...
Latent TB (Part 3) – moxa therapy, viability in the invisibility?
So far we’ve looked at some of the complexities and uncertainties relating to these so-called ‘latent’ aspects of a pandemic plague of...
Latent MDR-TB (Part 2): the invisible within the invisible
In Part 1 we discussed the nature of latent TB (LTBI), and some of the current (and recurrent) deficiencies in treating it. In this part,...
Latent tuberculosis (part 1) - The Invisible Plague
In the last month two studies have been published which have focused our attentions on latent TB - not least because their contents have...
